East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dapsone Gel, 5%. Aurobindo Pharma’s Dapsone Gel, are an AB-rated generic equivalent to the reference listed drug (RLD), Aczone Gel manufactured by AbbVie Inc.

Dapsone Gel are indicated for the:

• Topical treatment of acne vulgaris.